It’s only fair to share… Cinsebrutinib CAS 2724962-58-5 2-fluoro-1-[(3S)-1-prop-2-enoylpiperidin-3-yl]-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxamide Molecular Weight 383.46 Formula C22H26FN3O2 7BS8743F3E CINSEBRUTINIB is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. Cinsebrutinib is a Bruton’s tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib has the potential for cancer study. SCHEME INTERMEDIATE MAIN SYN example …